Craneofacial Injuries in Rink Hockey Athletes

Sponsor
University of Oviedo (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05400551
Collaborator
(none)
200
2
7.9
100
12.6

Study Details

Study Description

Brief Summary

To collect the number of injuries that affect the face and head in rink hockey athletes prospectively during a regular season.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    To collect the number of injuries that affect the face and head in rink hockey athletes prospectively during a regular season, while collecting athlete´s exposure and specifical injury characteristics (Burden, mechanism, situation, etc)

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Epidemiology of Craneofacial Injuries in Rink Hockey Athletes
    Anticipated Study Start Date :
    Sep 1, 2022
    Anticipated Primary Completion Date :
    Mar 30, 2023
    Anticipated Study Completion Date :
    Apr 30, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Number of participants injured [september 2022 to march 2023]

      nº of injuries affecting the head or face per time (X/1000h)

    2. days lost due to injury [september 2022 to march 2023]

      nº of days lost due to injury affecting the head or face per time (X days/1000h)

    Secondary Outcome Measures

    1. usage of helmet [september 2022 to march 2023]

      characterise if the player was using a helmet or not when the injury happened

    2. situational characteristics of the injury [september 2022 to march 2023]

      register when the injury happened (training or game)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Compete in a spanish rink hockey league

    • play at least in one game during ther regular season

    Exclusion Criteria:
    • do not accept the participation in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hugo Olmedillas Oviedo Asturias Spain 33006
    2 Universidad de Oviedo Oviedo Asturias Spain 33006

    Sponsors and Collaborators

    • University of Oviedo

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hugo Olmedillas Fernandez, Principal Investigator, University of Oviedo
    ClinicalTrials.gov Identifier:
    NCT05400551
    Other Study ID Numbers:
    • UO2022-01
    First Posted:
    Jun 1, 2022
    Last Update Posted:
    Jul 27, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hugo Olmedillas Fernandez, Principal Investigator, University of Oviedo
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 27, 2022